Investors considering Monopar should keep a close eye out for announcements about further development of ALXN-1840. Any updates on its MNPR-101 line of oncology products, all of which are either in ...
Michael Saylor's company MicroStrategy (NASDAQ: MSTR) has arguably been the best-performing stock in the market this year, even outperforming many of the artificial intelligence darlings that have ...